Cancer drug maker gave last-minute discount deal to HSE
The HSE declined to disclose the price reduction secured
The HSE secured a discount on the cancer medicine Pembrolizumab, after the manufacturer offered a last-minute price reduction.
In a letter to health minister Simon Harris, HSE director general Tony O’Brien said pharmaceutical company MSD had offered “revised commercial terms” in May.
In his June 2 letter to Harris, O’Brien confirmed that the HSE directorate had approved funding of the medicine, dubbed ‘Pembro’, which is used to treat advanced melanoma –...
Subscribe from just €1 for the first month!
Exclusive offers:
All Digital Access + eReader
Trial
€1
Unlimited Access for 1 Month
*New subscribers only
Annual
€200
€149 For the 1st Year
Unlimited Access for 1 Year
Quarterly
€55
€42
90 Day Pass
2 Yearly
€315
€248
Unlimited Access for 2 Years
Team Pass
Get a Business Account for you and your team
Related Stories
Analysis: Daily Covid cases could drop below 50 by March 5 if current rate continues
Our 14-day incidence has halved in the past ten days and numbers being admitted to ICU has started to slow
Dentist to the reality stars sets up Dublin clinic
Cosmetic specialist Slaine McGrath’s clients have included Sophie Hermann of Made in Chelsea and influencer Louise Thompson
Tony O’Brien: We need a face and a voice to lead the vaccine rollout
Vaccinating the population is a huge and tricky task: giving someone full authority over the enterprise would be a good start
Cathal Mac Coille: New Covid strains make credible travel restrictions essential
Public disillusion will increase if official ‘advice’ is seen as ineffective and loopholes regarding international travel remain unaddressed
